<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2506245429
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Floxmed
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVOFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        750
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        7
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        66.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Med city" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Med city
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Med City Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01AE05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Floxmed<sup>&reg;</sup></strong> contains a drug called levofloxacin.</p><p>Levofloxacin is an antibiotic which is used to treat bacterial infections of the:</p><p>Sinuses.</p><p>Lungs, in people with long-term breathing problems or pneumonia.</p><p>Urinary tract, including your kidneys and bladder.</p><p>Prostate gland, where you have a long lasting infection.</p><p>Skin and underneath the skin, including muscles. This is sometimes called &ldquo;soft tissue&rdquo;.</p><p>In some special situations, <strong>Floxmed<sup>&reg; </sup></strong>may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Floxmed<sup>&reg;</sup>:</strong></p><p>If you are allergic to levofloxacin, any other quinolone antibiotic such as moxifloxacin, ciprofloxacin or ofloxacin, or any of the other ingredients of this medicine.</p><p>Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>If your eyesight becomes impaired or if your eyes seem to be otherwise affected, consult an eye specialist immediately.</p><p>If you have ever had epilepsy.</p><p>If you have ever had a problem with your tendons such as tendonitis that was related to treatment with a &ldquo;quinolone antibiotic&rdquo;. A tendon is the cord that joins your muscle to your skeleton.</p><p>If you are a child or a growing teenager.</p><p>If you are pregnant, trying to become pregnant, or are breast-feeding.</p><p>Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking <strong>Floxmed<sup>&reg;</sup></strong>.</p><p><strong>Warnings and precautions:</strong></p><p><strong>Talk to your doctor, pharmacist or nurse before taking your medicine:</strong></p><p>If you are 60 years of age or older.</p><p>If you are using corticosteroids, sometimes called steroids.</p><p>If you have ever had a fit (seizure).</p><p>If you have had damage to your brain due to a stroke or other brain injury.</p><p>If you have kidney problems.</p><p>If you have a disease known as &ldquo;glucose-6-phosphate-dehydrogenase deficiency&rdquo;. You are more likely to have serious problems with your blood when taking this medicine.</p><p>If you have ever had mental health problems.</p><p>If you have ever had heart problems: caution should be taken when using this kind of medicine, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes).</p><p>If you are diabetic.</p><p>If you have ever had liver problems.</p><p>If you have myasthenia gravis.</p><p>Levofloxacin may rarely cause pain and inflammation in tendons. Particularly if you are elderly or are taking steroid medicines (such as cortisone or hydrocortisone). If you have any problems with your tendons whilst or shortly after taking levofloxacin, seek medical advice at once and rest the affected limb (leg or arm). Do not take the next dose of levofloxacin unless your doctor tells you to. In such as cases, you experience swelling or pain in the area of affected tendon. It may be necessary to stop treatment</p><p>If you start having severe, persistent and/or bloody diarrhea during or after treatment with levofloxacin, tell your doctor immediately. This could mean you have serious inflammation of your bowel (pseudomembranous colitis), which can sometimes occur after antibiotic treatment. You may need to stop taking levofloxacin and for your doctor to give you another medicine.</p><p>Whilst taking <strong>Floxmed<sup>&reg; </sup></strong>you are advised to stay out of strong sunlight and not to use a sun lamp. This is because some patients may become more sensitive to light whilst taking the tablets and get a sun‐burn like reaction.</p><p>Levofloxacin should be discontinued if the patient experiences symptoms Burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;.</p><p>Levofloxacin is not an optimal therapy for most severe cases of Pneumococcal pneumonia.</p><p>Infections got from a hospital during treatment due to P. aeruginosa may require combination therapy.</p><p>Levofloxacin is not effective against infections caused by MRSA. In infections suspicious for MRSA levofloxacin should be combined with an agent approved to treat MRSA infections.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking <strong>Floxmed<sup>&reg; </sup></strong>Tablets.</p><p><strong>Other medicines and Floxmed<sup>&reg;</sup></strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because <strong>Floxmed<sup>&reg; </sup></strong>can affect the way other medicines work. Also, some medicines can affect the way <strong>Floxmed<sup>&reg; </sup></strong>works.<br /><strong>In particular, tell your doctor if you are taking any of the following medicines. This is because it can increase the chance of you getting side effects, when taken with Floxmed<sup>&reg;</sup>:</strong></p><p>Corticosteroids, sometimes called steroids &ndash; used for inflammation. You may be more likely to have inflammation and/or rupture of your tendons.</p><p>Warfarin &ndash; used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.</p><p>Theophylline &ndash; used for breathing problems. You are more likely to have a fit (seizure) if taken with <strong>Floxmed<sup>&reg;</sup></strong>.</p><p>Non-steroidal anti-inflammatory drugs (NSAIDs) - used for pain and inflammation such as aspirin, ibuprofen, fenbufen, ketoprofen and indomethacin. You are more likely to have a fit (seizure) if taken with <strong>Floxmed<sup>&reg;</sup></strong>.</p><p>Ciclosporin &ndash; used after organ transplants. You may be more likely to get the side effects of ciclosporin.</p><p>Medicines known to affect the way your heart beats. This includes medicines used for abnormal heart rhythm (antiarrhythmics such as quinidine, hydroquinidine, disopyramide, sotalol, dofetilide and ibutilide and amiodarone), for depression (tricyclic antidepressants such as amitriptyline and imipramine), for psychiatric disorders (antipsychotics), and for bacterial infections (&lsquo;macrolide&rsquo; antibiotics such as erythromycin, azithromycin and clarithromycin).</p><p>Probenecid &ndash; used for gout and cimetidine &ndash; used for ulcers and heartburn. Special care should be taken when taking either of these medicines with <strong>Floxmed</strong><sup>&reg;</sup>. If you have kidney problems, your doctor may want to give you a lower dose.</p><p>Do not take <strong>Floxmed<sup>&reg;</sup></strong> at the same time as the following medicines. This is because it can affect the way <strong>Floxmed</strong><sup>&reg;</sup> work:</p><p>Iron tablets (for anemia), zinc supplements, magnesium or aluminum-containing antacids (for acid or heartburn), didanosine or sucralfate (for stomach ulcers).</p><p><strong>Urine tests for opiates</strong></p><p>Urine tests may show &ldquo;false-positive&rdquo; results for strong painkillers called &lsquo;opiates&rsquo; in people taking <strong>Floxmed</strong><sup>&reg;</sup>. If your doctor is due to take a urine test, tell them you are taking <strong>Floxmed</strong><sup>&reg;</sup>.</p><p><strong>Tuberculosis test</strong></p><p>This medicine may cause &ldquo;false negative&rdquo; results for some test used in laboratory to search for the bacteria causing tuberculosis.</p><p><strong>Floxmed<sup>&reg; </sup>with food and drink</strong></p><p>Take without regard to meals. Take with water, drink with plenty of water. Taking this product with orange juice can result in reduced quinolone plasma levels.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>You must not take <strong>Floxmed</strong><sup>&reg; </sup>if you are pregnant, trying to become pregnant or are breastfeeding.</p><p><strong>Driving and using machines</strong></p><p>You may get side effects after taking this medicine, including feeling dizzy, sleepy, a spinning feeling (vertigo) or changes to your eyesight. Some of these side effects can affect you being able to concentrate and your reaction speed. If this happens, do not drive or carry out any work that requires a high level of attention.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine</strong></p><p>Take this medicine by mouth.</p><p>Swallow the tablets whole with a drink of water.</p><p>The tablets may be taken during meals or at any time between meals.</p><p><strong>Protect your skin from sunlight</strong></p><p>Keep out of direct sunlight while taking this medicine and for 2 days after you stop taking it. This is because your skin will become much more sensitive to the sun and may burn, tingle or severely blister if you do not take the following precautions:</p><p>Make sure you use high factor sun cream.</p><p>Always wear a hat and clothes which cover your arms and legs.</p><p>Avoid sun beds.</p><p><strong>If you are already taking iron tablets, zinc supplements, antacids, didanosine or sucralfate</strong></p><p>Do not take these medicines at the same time as <strong>Floxmed</strong><sup>&reg;</sup>. Take your dose of these medicines at least 2 hours before or after <strong>Floxmed</strong><sup>&reg;</sup>.</p><p><strong>How much to take</strong></p><p>Your doctor will decide on how many <strong>Floxmed</strong><sup>&reg; </sup>tablets you should take.</p><p>The dose will depend on the type of infection you have and where the infection is in your body.</p><p>The length of your treatment will depend on how serious your infection is.</p><p>If you feel the effect of your medicine is too weak or strong, do not change the dose yourself, but ask your doctor.</p><p><strong>Adults and the elderly</strong></p><p><strong>Acute Sinuses infections</strong></p><p>Two tablets of levofloxacin 250 mg, once each day for 10‐14 days.</p><p>Or, one tablet of <strong>Floxmed</strong><sup>&reg; </sup>500 mg, once each day for 10‐14 days.</p><p>One tablet of <strong>Floxmed</strong><sup>&reg; </sup>750 mg, once each day for 5 days.</p><p><strong>Pneumonia</strong></p><p><strong>Community-Acquired Pneumonia:</strong></p><p>Two tablets of levofloxacin 250 mg, once or twice each day for 7-14 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, once or twice each day for 7-14 days.</p><p>One tablet of <strong>Floxmed<sup>&reg; </sup></strong>750 mg, once each day for 5 days.</p><p><strong>Acute bacterial exacerbation of chronic bronchitis:</strong></p><p>Two tablets of levofloxacin 250 mg, once each day for 7-10 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, once each day for 7-10 days.</p><p><strong>Complicated urinary tract infection:</strong></p><p>Two tablets of levofloxacin 250 mg, each day for 7-14 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, each day for 7-14 days.</p><p>One tablet of <strong>Floxmed<sup>&reg; </sup></strong>750 mg, once each day for 5 days.</p><p><strong>Acute pyelonephritis:</strong></p><p>Two tablets of levofloxacin 250 mg, each day for 7-10 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, each day for 7-10 days.</p><p>One tablet of <strong>Floxmed<sup>&reg; </sup></strong>750 mg, once each day for 5 days.</p><p><strong>Uncomplicated urinary tract infection:</strong></p><p>One tablet of levofloxacin 250 mg, each day for 3 days.</p><p><strong>Chronic bacterial prostatitis:</strong></p><p>Two tablets of levofloxacin 250 mg, once each day for 28 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, once each day for 28 days.</p><p><strong>Complicated skin and skin structure infections (SSSI):</strong></p><p>Two tablets of levofloxacin 250 mg, once or twice each day for 7-14 days.</p><p>Or, one tablet of <strong>Floxmed<sup>&reg; </sup></strong>500 mg, once or twice each day for 7-14 days.</p><p>One tablet of <strong>Floxmed<sup>&reg; </sup></strong>750 mg, once each day for 7-14 days.</p><p><strong>Adults and the elderly with kidney problems</strong></p><p>Your doctor may need to give you a lower dose.</p><p><strong>Children and teenagers</strong></p><p>This medicine must not be given to children or teenagers below 18 years.</p><p><strong>If you take more Floxmed<sup>&reg; </sup>than you should</strong></p><p>If you accidentally take more tablets than you should, tell a doctor or get other medical advice straight away. Take the medicine pack with you. This is so the doctor knows what you have taken. The following effects may happen: convulsive fits (seizures), feeling confused, dizzy, less conscious, having tremor and heart problems - leading to uneven heart beats as well as feeling sick (nausea) or having stomach burning.</p><p><strong>If you forget to take Floxmed<sup>&reg;</sup></strong></p><p>If you forget to take a dose, take it as soon as you remember unless it is nearly time for your next dose.</p><p>Do not double-up the next dose to make up for the missed dose.</p><p><strong>If you stop taking Floxmed</strong><sup>&reg;</sup></p><p>Do not stop taking <strong>Floxmed</strong><sup>&reg; </sup>just because you feel better. It is important that you complete the course of tablets that your doctor has prescribed for you. If you stop taking the tablets too soon, the infection may return, your condition may get worse, or the bacteria may become resistant to the medicine.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>These effects are normally mild or moderate and often disappear after a short time.</p><p><strong>Stop taking levofloxacin<sup> </sup>and see a doctor or go to a hospital straight away if you notice the following side effect:</strong></p><p><strong>Very rare&nbsp;(may affect up to 1 in 10000 people)</strong></p><p>You have allergic reactions. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p><strong>Stop taking levofloxacin<sup> </sup>and see a doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:</strong></p><p><strong>Rare&nbsp;(may affect up to 1 in 1000 people)</strong></p><p>Watery diarrhea which may have blood in it, possibly with stomach cramps and a high temperature. These could be signs of a severe bowel problem.</p><p>Pain and inflammation in your tendons or ligaments which could lead to rupture. The Achilles tendon is affected most often.</p><p>&nbsp;Fits (convulsions).</p><p><strong>Very rare&nbsp;(may affect up to 1 in 10000 people)</strong></p><p>Burning, tingling, pain or numbness. These may be signs of something called &ldquo;neuropathy&rdquo;.</p><p><strong>Other:</strong></p><p>Severe skin rashes which may include blistering or peeling of the skin around your lips, eyes, mouth, nose and genitals</p><p>Loss of appetite, skin and eyes becoming yellow in color, dark-colored urine, itching, or tender stomach (abdomen). These may be signs of liver problems which may include a fatal failure of the liver.</p><p>If your eyesight becomes impaired or if you have any other eye disturbances whilst taking levofloxacin, you must consult an eye specialist immediately.</p><p><strong>Tell your doctor if any of the following side effects gets serious or lasts longer than a few days:</strong></p><p><strong>Common&nbsp;(may affect up to 1 in 10 people)</strong></p><p>Sleeping problems.</p><p>Headache, feeling dizzy.</p><p>Feeling sick (nausea, vomiting) and diarrhea.</p><p>Increase in the level of some liver enzymes in your blood.</p><p><strong>Uncommon&nbsp;(may affect up to 1 in 100 people)</strong></p><p>Changes in the number of other bacteria or fungi, infection by fungi named Candida, which may need to be treated.</p><p>Changes in the number of white blood cells shown up in the results of some blood tests (leukopenia, eosinophilia).</p><p>Feeling stressed (anxiety), feeling confused, feeling nervous, feeling sleepy, trembling, a spinning feeling (vertigo).</p><p>Shortness of breath (dyspnea).</p><p>Changes in the way things taste, loss of appetite, stomach upset or indigestion (dyspepsia), pain in your stomach area, feeling bloated (flatulence) or constipation.</p><p>Itching and skin rash, severe itching or hives (urticaria), sweating too much (hyperhidrosis).</p><p>Joint pain or muscle pain.</p><p>Blood tests may show unusual results due to liver (bilirubin increased) or kidney (creatinine increased) problems.</p><p>General weakness.</p><p><strong>Rare&nbsp;(may affect up to 1 in 1000 people)</strong></p><p>Bruising and bleeding easily due to a lowering in the number of blood platelets (thrombocytopenia).</p><p>Low number of white blood cells (neutropenia).</p><p>Exaggerated immune response (hypersensitivity).</p><p>Lowering of your blood sugar levels (hypoglycaemia). This is important for people that have diabetes.</p><p>Seeing or hearing things that are not there (hallucinations, paranoia), change in your opinion and thoughts (psychotic reactions) with a risk of having suicidal thoughts or actions.</p><p>Feeling depressed, mental problems, feeling restless (agitation), abnormal dreams or nightmares.</p><p>Tingly feeling in your hands and feet (paresthesia).</p><p>Problems with your hearing (tinnitus) or eyesight (blurred vision).</p><p>Unusual fast beating of your heart (tachycardia) or low blood pressure (hypotension).</p><p>Muscle weakness. This is important in people with myasthenia gravis (a rare disease of the nervous system).</p><p>Changes in the way your kidney works and occasional kidney failure which may be due to an allergic kidney reaction called interstitial nephritis.</p><p>Fever</p><p><strong>Other side effect:</strong></p><p>Lowering in red blood cells (anemia): this can make the skin pale or yellow due to damage of the red blood cells; lowering in the number of all types of blood cells (pancytopenia).</p><p>Fever, sore throat and a general feeling of being unwell that does not go away. This may be due to a lowering in the number of white blood cells (agranulocytosis).</p><p>Loss of circulation (anaphylactic-like shock).</p><p>Increase of your blood sugar levels (hyperglycemia), or lowering of your blood sugar levels leading to coma (hypoglycaemic coma). This is important for people that have diabetes.</p><p>Changes in the way things smell, loss of smell or taste (parosmia, anosmia, ageusia).</p><p>Problems moving and walking (dyskinesia, extrapyramidal disorders).</p><p>Temporary loss of consciousness or posture (syncope).</p><p>Temporary loss of vision.</p><p>Impairment or loss of hearing.</p><p>Abnormal fast heart rhythm, life-threatening irregular heart rhythm including cardiac arrest, alteration of the heart rhythm (called &ldquo;prolongation of QT interval&rdquo;, seen on ECG, electrical activity of the heart).</p><p>Difficulty breathing or wheezing (bronchospasm).</p><p>Allergic lung reactions.</p><p>Pancreatitis.</p><p>Inflammation of the liver (hepatitis).</p><p>Increased sensitivity of your skin to sun and ultraviolet light (photosensitivity).</p><p>Inflammation of the vessels that carry blood around your body due to an allergic reaction (vasculitis).</p><p>Inflammation of the tissue inside the mouth (stomatitis).</p><p>Muscle rupture and muscle destruction (rhabdomyolysis).</p><p>Joint redness and swelling (arthritis).</p><p>Pain, including pain in the back, chest and extremities.</p><p>Attacks of porphyria in people who already have porphyria (a very rare metabolic disease).</p><p>Persistent headache with or without blurred vision (benign intracranial hypertension).</p><p><strong>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Floxmed<sup>&reg;</sup></strong> tablets after the expiry date (EXP) which is stated on the Label and the carton.</p><p>The expiry date refers to the last day of that month.</p><p><strong>Floxmed<sup>&reg;</sup></strong> tablets: Store below 30&deg;C.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is levofloxacin (hemihydrate).</p><p>The other ingredients are microcrystalline cellulose, sodium starch glycolate, povidone K30, colloidal anhydrous silica, magnesium stearate, Opadry OY-L white, black iron oxide, yellow iron oxide, polyethylene glycol 6000.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Floxmed® 750mg Film Coated Tablet, Beige to brownish yellow oval deep biconvex film coated tablets engraved with H22 on one face and plain on the other face, packed in HDPE Jars, intended for oral use.
Pack size: 7 film coated tablets/Jar.

To report any side effect(s):
•Saudi Arabia:
The National Pharmacovigilance Center (NPC):
SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa
Website: https://ade.sfda.gov.sa
•Other GCC States:
Please contact the relevant competent authority.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Med City Pharma-KSA.</p><p>1st Industrial city, Phase 5, Jeddah &ndash;KSA.</p><p>Tel: 00966920003288</p><p>Mobile: 00966555786968</p><p>P.O .Box: 4072 - Jeddah 22429</p><p>E-mail: info@medcitypharma.com</p><p>&nbsp;</p><p>This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 12/2024    
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>على دواء يسمى ليڤوفلوكساسين.</p><p dir="RTL">يعد ليڤوفلوكساسين مضاد حيوي يستعمل لعلاج الالتهابات البكتيرية التالية:</p><p dir="RTL">الجيوب الأنفية.</p><p dir="RTL">الرئتين، عند الأشخاص الذين يعانون من مشاكل طويلة الأمد في التنفس أو التهاب الرئة.</p><p dir="RTL">المسالك البولية، بما في ذلك الكلى و المثانة.</p><p dir="RTL">غدة البروستات، في حال كنت تعاني من التهاب طويل الأمد.</p><p dir="RTL">الجلد وتحت الجلد، بما في ذلك العضلات. وهذا يسمى أحيانا &ldquo;الأنسجة الرخوة&rdquo;.</p><p dir="RTL">في بعض الحالات الخاصة، يمكن استعمال <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>لتقليل احتمالية الإصابة بمرض رئوي يسمى الجمرة الخبيثة أو زيادة المرض سوءا بعد تعرضك للبكتيريا المسببة للجمرة الخبيثة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب</strong><strong> </strong><strong>عدم</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong><strong>في</strong><strong> </strong><strong>الحالات</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL">إذا كنت تعاني من تحسس لليڤوفلوكساسين، أي من المضادات الحيوية الأخرى من مجموعة كوينولون مثل موكسيفلوكساسين، سيبروفلوكساسين أو أوفلوكساسين، أو لأي مكونات أخرى في هذا الدواء.</p><p dir="RTL">تتضمن علامات التفاعل التحسسي: طفح، مشاكل في البلع أو التنفس، تورم الشفاه، الوجه، الحلق أو اللسان.</p><p dir="RTL">إذا أصبحت تعاني من ضعف البصر أو بدأت العيون تتأثر بطريقة أخرى، قم باستشارة أخصائي العيون على الفور.</p><p dir="RTL">إذا عانيت سابقا من الصرع.</p><p dir="RTL">إذا عانيت سابقا من مشكلة في الأوتار مثل، التهاب الأوتار و كانت مرتبطة بالعلاج باستعمال &ldquo;مضاد حيوي من مجموعة كوينولون&rdquo;. الوتر هو الرباط الذي يربط بين العضلة و الهيكل العظمي.</p><p dir="RTL">&nbsp;إذا كنت طفل أو مراهقا في مرحلة النمو.</p><p dir="RTL">إذا كنت حامل، تحاولين الحمل أو مرضعة.</p><p dir="RTL">لا تتناول هذا الدواء إذا كان أي مما ذكر في الأعلى ينطبق عليك. إذا كنت غير متأكد، تحدث مع طبيبك أو الصيدلي قبل تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL"><strong>الاحتياطات</strong><strong> </strong><strong>والمحاذير</strong></p><p dir="RTL"><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك،</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الممرض</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>دوائك</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الحالات</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL">إذا كان عمرك 60 عاما أو أكبر.</p><p dir="RTL">إذا كنت تستعمل الستيرويدات القشرية، أحيانا تسمى الستيرويدات.</p><p dir="RTL">إذا عانيت سابقا من نوبات ظهور أعراض مفاجئة (نوبات صرع).</p><p dir="RTL">إذا عانيت سابقا من تلف في الدماغ نتيجة سكتة أو إصابة أخرى في الدماغ.</p><p dir="RTL">إذا كنت تعاني من مشاكل في الكلى.</p><p dir="RTL">إذا كنت تعاني من مرض يسمى &ldquo;نقص إنزيم جلوكوز-6- فوسفات-ديهيدروجينيز&rdquo;. سيزيد احتمال حدوث مشاكل خطيرة في الدم عند تناول هذا الدواء.</p><p dir="RTL">إذا عانيت سابقا من مشاكل في الصحة العقلية.</p><p dir="RTL">إذا عانيت سابقا من مشاكل في القلب: يجب أخذ الحيطة عند تناول هذا النوع من الأدوية، إذا ولدت و أنت مصاب أو لديك تاريخ عائلي للإصابة بإطالة فترة QT (يظهر خلال تخطيط القلب الكهربائي)، تعاني من عدم توازن الأملاح في الدم (خاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم)، تعاني من بطء شديد في نظمية نبضات القلب (تسمى &ldquo;بطء القلب&rdquo;)، لديك قلب ضعيف (قصور في وظيفة عضلة القلب)، لديك تاريخ للإصابة بنوبة قلبية (احتشاء عضلة القلب)، كنت أنثى أو شخص كبير في السن أو كنت تتناول أدوية أخرى ينتج عنها تغييرات غير طبيعية في تخطيط القلب الكهربائي).</p><p dir="RTL">إذا كنت تعاني من داء السكري.</p><p dir="RTL">إذا عانيت سابقا من مشاكل في الكبد.</p><p dir="RTL">إذا كنت تعاني من وهن عضلي وبيل.</p><p dir="RTL">قد يسبب ليڤوفلوكساسين نادرا ألم و التهاب في الأوتار. خصوصا إذا كنت من كبار السن أو تتناول أدوية الستيرويد (مثل، كورتيزون أو هيدروكورتيزون). إذا كنت تعاني من أي مشاكل في الأوتار أثناء تناول ليڤوفلوكساسين أو بعد فترة قصيرة من تناوله، اطلب الاستشارة الطبية فورا و أرح الطرف المتأثر (الساق أو الذراع). لا تتناول الجرعة التالية من ليڤوفلوكساسين ما لم يخبرك طبيبك بذلك. في مثل هذه الحالات، إذا شعرت بتورم أو ألم في منطقة الوتر المتأثر، قد يكون من الضروري التوقف عن العلاج.</p><p dir="RTL">إذا بدأت تعاني من ألم حاد، مستمر و/أو أسهال يرافقه ظهور الدم أثناء أو بعد العلاج باستعمال ليڤوفلوكساسين، أخبر طبيبك فورا. هذا قد يعني بأنك تعاني من التهاب خطير في الأمعاء (التهاب القولون الغشائي الكاذب)، الذي قد يحدث أحيانا بعد العلاج باستعمال المضادات الحيوية. قد تحتاج إلى التوقف عن تناول ليڤوفلوكساسين و يحتاج طبيبك إلى إعطائك دواء آخر.</p><p dir="RTL">يُنصح بالابتعاد عن أشعة الشمس القوية أثناء تناول ليڤوفلوكساسين و عدم استعمال المصابيح التي تصدر أشعة فوق بنفسجية. و ذلك لأن بعض المرضى قد يصبحون أكثر حساسية للضوء أثناء تناول الأقراص ويعانون من تفاعلات تشبه حروق الشمس.</p><p dir="RTL">يجب التوقف عن تناول ليڤوفلوكساسين إذا عانى المريض من أعراض مثل: الشعور بالحرقة، وخز، ألم أو تنميل. قد تكون هذه علامات لحالة تسمى &quot;اعتلال الأعصاب&quot;.</p><p dir="RTL">لا يعد ليڤوفلوكساسين علاج مثالي لمعظم حالات التهاب الرئة الحاد الناتج عن المكورات الرئوية.</p><p dir="RTL">قد تتطلب الالتهابات المكتسبة من المستشفى أثناء العلاج بسبب بكتيريا سودومونوس إيروجينوزا استعمال علاج مركب.</p><p dir="RTL">ليڤوفلوكساسين غير فعال ضد الالتهابات الناتجة عن المكورات العنقودية الذهبية المقاومة للميثيسيلين. في الالتهابات المشتبه بأنها ناتجة عن المكورات العنقودية الذهبية المقاومة للميثيسيلين، يجب استعمال ليڤوفلوكساسين بالتزامن مع عامل معتمد لعلاج الالتهابات الناتجة عن المكورات العنقودية الذهبية المقاومة للميثيسيلين.</p><p dir="RTL">إذا لم تكن متأكدا إذا كان أي مما ذكر في الأعلى ينطبق عليك، تحدث مع طبيبك أو الصيدلي قبل تناول أقراص <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><sup>.</sup></p><p dir="RTL"><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخرا أو من الممكن أن تتناول أي أدوية أخرى. وهذا لأن <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong> قد يؤثر على طريقة عمل الأدوية الأخرى. أيضا، قد توثر بعض الأدوية على طريقة عمل <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL"><strong>بشكل</strong><strong> </strong><strong>خاص،</strong><strong> </strong><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الأدوية</strong><strong> </strong><strong>التالية</strong><strong>. </strong><strong>وذلك</strong><strong> </strong><strong>لأنها</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تزيد</strong><strong> </strong><strong>من</strong><strong> </strong><strong>فرصة</strong><strong> </strong><strong>تعرضك</strong><strong> </strong><strong>للأثار</strong><strong> </strong><strong>الجانبية،</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>تناولها</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong>:</strong></p><p dir="RTL">الستيرويدات القشرية، أحيانا تسمى ستيرويدات &ndash; تستعمل لعلاج الالتهاب. قد تصبح معرضا أكثر لحدوث التهاب و/أو تمزق في الأوتار .</p><p dir="RTL">وارفارين &ndash; يستعمل للوقاية من تجلط الدم. قد تصبح أكثر عرضة للإصابة بنزيف. قد يحتاج طبيبك إلى إجراء فحوصات دم منتظمة لتقييم عملية تجلط الدم.</p><p dir="RTL">ثيوفيلين &ndash; يستعمل لمشاكل التنفس. قد تصبح أكثر عرضة للإصابة بنوبات ظهور أعراض مفاجئة (نوبات صرع) في حال تناوله مع <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL">الأدوية غير الستيرويدية المضادة للالتهاب &ndash; تستعمل للألم و الالتهاب مثل الأسبرين، أيبوبروفين، فينبوفين، كيتوبروفين و إندوميثاسين. قد تصبح أكثر عرضة للإصابة بنوبات ظهور أعراض مفاجئة (نوبات صرع) في حال تناوله مع <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL">سكلوسبورين &ndash;&nbsp; يستعمل بعد زراعة الأعضاء. قد تصبح أكثر عرضة للإصابة بالآثار الجانبية المصاحبة لتناول سكلوسبورين.</p><p dir="RTL">الأدوية المعروف بأنها تؤثرعلى طريقة نبض القلب. هذا يتضمن الأدوية التي تستعمل لاضطراب نظمية القلب (مضادات اضطراب نظمية القلب مثل كوينيدين، هيدروكوينيدين، ديسوبيرامايد، سوتالول، دوفيتيلايد و أيبوتيلايد و أميودارون)، لعلاج الاكتئاب (مضادات الاكتئاب ثلاثية الحلقة مثل أميتريبتيلين و أيميبرامين)، لعلاج اضطرابات الذهان (مضادات الذهان)، و لعلاج الالتهابات البكتيرية (المضادات الحيوية من مجموعة الماكروليد مثل إيريثرومايسين، أزيثرومايسين و كلاريثرومايسين).</p><p dir="RTL">بروبينيسيد &ndash;&nbsp; يستعمل لعلاج النقرس و سيميتيدين &ndash; يستعمل للعلاج القرحة وحرقة المعدة. يجب أخذ الحذر بشكل خاص عند تناول أي من هذه الأدوية مع <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>. إذا كانت لديك مشاكل في الكلى، قد يرغب الطبيب في إعطائك جرعة أقل.</p><p dir="RTL">تجنب تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>في نفس الوقت مع الأدوية التالية. لأنه من الممكن أن تؤثر على طريقة عمل<strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><sup>:</sup></p><p dir="RTL">أقراص الحديد (لعلاج فقر الدم)، مكملات الزنك، مضادات الحموضة المحتوية على المغنيسيوم أو الألومنيوم (للحموضة أو حرقة المعدة)، ديدانوسين أو سكرالفات (لعلاج قرحة المعدة).</p><p dir="RTL"><strong>فحوصات</strong><strong> </strong><strong>البول</strong><strong> </strong><strong>للمواد</strong><strong> </strong><strong>الأفيونية</strong></p><p dir="RTL">قد تظهر فحوصات البول نتائج &ldquo;إيجابية &ndash; خاطئة&rdquo; لمسكنات الألم القوية التي تسمى &ldquo;الأفيونات&rdquo; عند الأشخاص الذين يتناولون <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>. إذا طلب منك الطبيب القيام بفحص البول، أخبرهم بأنك تتناول<sup> </sup><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><sup>.</sup></p><p dir="RTL"><strong>فحوصات</strong><strong> </strong><strong>السل</strong></p><p dir="RTL">قد يسبب هذا الدواء ظهور نتائج &ldquo;سلبية خاطئة&rdquo; لبعض الفحوصات التي تستعمل في الختبر التي تكشف عن البكتيريا المسببة للسل.</p><p dir="RTL"><strong>تناول</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong><strong>مع</strong><strong> </strong><strong>الطعام</strong><strong> </strong><strong>و</strong><strong> </strong><strong>الشراب</strong></p><p dir="RTL">تناوله بغض النظر عن وقت تناول الوجبات. تناوله مع الماء، اشرب كثير من الماء. قد يؤدي تناول هذا المستحضر مع عصير البرتقال إلى انخفاض مستويات الكينولون في البلازما.</p><p dir="RTL"><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p dir="RTL">يجب عدم تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>إذا كنت حامل، تحاولين الحمل أو كنت مرضعة.</p><p dir="RTL"><strong>القيادة</strong><strong> </strong><strong>و</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>الآلات</strong><strong> </strong></p><p dir="RTL">قد تعاني من آثار جانبية بعد تناول هذا الدواء، بما في ذلك الشعور بالدوار، الشعور بالنعاس، الشعور بالدوران (دوخة) أو التغيرات في الرؤية. قد تؤثر بعض هذه الآثار الجانبية على قدرتك على التركيز وسرعة رد الفعل. إذا حدث هذا، تجنب القيادة أو القيام بأي عمل يتطلب مستوى عال من الانتباه.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول هذا الدواء<strong><sup> </sup></strong>تماما كما أخبرك طبيبك. تأكد من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL"><strong>تناول</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء</strong></p><p dir="RTL">تناول الدواء عن طريق الفم.</p><p dir="RTL">تناول الأقراص كاملة مع شرب الماء.</p><p dir="RTL">من الممكن تناول الأقراص أثناء الوجبات أوفي أي وقت بين الوجبات.</p><p dir="RTL"><strong>حماية</strong><strong> </strong><strong>الجلد</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أشعة</strong><strong> </strong><strong>الشمس</strong></p><p dir="RTL">تجنب التعرض لأشعة الشمس المباشرة أثناء تناول هذا الدواء و لمدة يومين بعد التوقف عن تناوله. وذلك لأن جلدك سيصبح أكثر حساسية لأشعة الشمس وقد يتعرض للحروق، الشعور بالوخز أو ظهور تنفطات (بثور) بشكل حاد إذا لم تتخذ الاحتياطات التالية :</p><p dir="RTL">التأكد من استعمال كريم واقي من الشمس بمعامل حماية عالي.</p><p dir="RTL">ارتد دائما قبعة و ملابس تغطي الذراعين و الساقين.</p><p dir="RTL">تجنب استخدام أجهزة تسمير البشرة.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>الحديد،</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>الزنك،</strong><strong> </strong><strong>مضادات</strong><strong> </strong><strong>الحموضة،</strong><strong> </strong><strong>ديدانوسين،</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>سكرالفات</strong><strong> </strong></p><p dir="RTL">لا تتناول هذه الأدوية في نفس وقت تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>. تناول جرعتك من هذه الأدوية بعد أو قبل ساعتين على الأقل من تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong>.</p><p dir="RTL"><strong>الجرعة</strong><strong> </strong></p><p dir="RTL">سيقرر طبيبك عدد أقراص <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>التي يجب تناولها.</p><p dir="RTL">ستعتمد الجرعة على نوع الالتهاب الذي تعاني منه و مكانه في الجسم.</p><p dir="RTL">ستعتمد مدة العلاج على خطورة الالتهاب.</p><p dir="RTL">إذا شعرت بأن تأثير الدواء ضعيف جدا أو قوي جدا، لا تغير الجرعة بنفسك، لكن اسأل طبيبك.</p><p dir="RTL"><strong>البالغون</strong><strong> </strong><strong>و</strong><strong> </strong><strong>كبار</strong><strong> </strong><strong>السن</strong></p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>الجيوب</strong><strong> </strong><strong>الأنفية</strong><strong> </strong><strong>الحاد</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، مرة واحدة كل يوم لمدة 10 - 14 يوم.</p><p dir="RTL">أو، قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>500 ملغم، مرة واحدة كل يوم لمدة 10 - 14 يوم.</p><p dir="RTL">قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>750 ملغم، مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>الرئة</strong></p><p dir="RTL"><strong>الالتهاب</strong><strong> </strong><strong>الرئوي</strong><strong> </strong><strong>المكتسب</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المستشفى</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، مرة واحدة أو مرتين كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">أو، قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>500 ملغم، مرة واحدة أو مرتين كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>750 ملغم، مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL"><strong>التفاقم</strong><strong> </strong><strong>الحاد</strong><strong> </strong><strong>لالتهاب</strong><strong> </strong><strong>القصبات</strong><strong> </strong><strong>الهوائية</strong><strong> </strong><strong>البكتيري</strong><strong> </strong><strong>المزمن</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، مرة واحدة كل يوم لمدة 7 - 10 أيام.</p><p dir="RTL">أو، قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>500 ملغم، مرة واحدة كل يوم لمدة 7 - 10 أيام.</p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>المسالك</strong><strong> </strong><strong>البولية</strong><strong> </strong><strong>المعقد</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">أو، قرص من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>500 ملغم، كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">قرص من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>750 ملغم، مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>الحويضة</strong><strong> </strong><strong>والكلية</strong><strong> </strong><strong>الحاد</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، كل يوم لمدة 7 - 10 أيام.</p><p dir="RTL">أو، قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>500 ملغم، كل يوم لمدة 7 - 10 أيام.</p><p dir="RTL">قرص من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>750 ملغم، مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>المسالك</strong><strong> </strong><strong>البولية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>المعقد</strong><strong>:</strong></p><p dir="RTL">قرص واحد من ليڤوفلوكساسين 250 ملغم، كل يوم لمدة 3 أيام.</p><p dir="RTL"><strong>التهاب</strong><strong> </strong><strong>غدة</strong><strong> </strong><strong>البروستات</strong><strong> </strong><strong>البكتيري</strong><strong> </strong><strong>المزمن</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، مرة واحدة كل يوم لمدة 28 يوم.</p><p dir="RTL">&nbsp;أو قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>500 ملغم، مرة واحدة كل يوم لمدة 28 يوم.</p><p dir="RTL"><strong>التهابات</strong><strong> </strong><strong>الجلد</strong><strong> </strong><strong>و</strong><strong> </strong><strong>بنية</strong><strong> </strong><strong>الجلد</strong><strong> </strong><strong>المعقدة</strong><strong>:</strong></p><p dir="RTL">قرصين من ليڤوفلوكساسين 250 ملغم، مرة واحدة كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">أو، قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>500 ملغم، مرة واحدة أو مرتين كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL">قرص واحد من <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>750 ملغم، مرة واحدة كل يوم لمدة 7 - 14 أيام.</p><p dir="RTL"><strong>البالغون</strong><strong> </strong><strong>و</strong><strong> </strong><strong>كبار</strong><strong> </strong><strong>السن</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يعانون</strong><strong> </strong><strong>من</strong><strong> </strong><strong>مشاكل</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الكلى</strong></p><p dir="RTL">قد يحتاج طبيبك إعطائك جرعة أقل.</p><p dir="RTL"><strong>الأطفال</strong><strong> </strong><strong>و</strong><strong> </strong><strong>المراهقون</strong></p><p dir="RTL">يجب عدم إعطاء هذا الدواء للأطفال و المراهقين الذين تقل أعمارهم عن 18 عام.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p dir="RTL">إذا تناولت<strong> </strong>أكثر مما يجب من الأقراص عن طريق الخطأ، أخبر طبيبك أو احصل على استشارة طبية أخرى على الفور. خذ معك علبة الدواء. ليعرف طبيبك ماذا تناولت. قد تحدث التأثيرات التالية: نوبات ظهور أعراض تشنجية مفاجئة (نوبات صرع)، الشعور بالارتباك، الشعور بالدوار، الشعور بقلة الوعي، ارتعاش و مشاكل في القلب - مما يؤدي إلى عدم تساوي نبضات القلب بالإضافة إلى الشعور بالغثيان أو الشعور بحرقة في المعدة.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">إذا نسيت تناول جرعة، تناولها فور تذكرك إلا إذا حان وقت تناول الجرعة التالية.</p><p dir="RTL">لا تضاعف الجرعة التالية لتعويض الجرعة التي نسيتها.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>توقفت</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">لا تتوقف عن تناول <strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>فقط لأنك شعرت بتحسن. من المهم أن تكمل العلاج الذي وصفه لك الطبيب، إذا توقفت عن تناول الدواء قبل إكماله، قد يعود الالتهاب مرة أخرى، قد تزداد حالتك سوءا أو تصبح البكتيريا مقاومة للعلاج.</p><p dir="RTL">إذا كان لديك أي أسئلة إضافية عن استعمال هذا الدواء، إسأل طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء<strong><sup> </sup></strong>آثار جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">هذه التأثيرات هي عادة معتدلة أو متوسطة و غالبا تختفي بعد فترة قصيرة.</p><p dir="RTL"><strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>ليڤوفلوكساسين</strong><strong> </strong><strong>و</strong><strong> </strong><strong>اذهب</strong><strong> </strong><strong>لرؤية</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>اذهب</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>المستشفى</strong><strong> </strong><strong>فورا</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>التالية</strong><strong>: </strong></p><p dir="RTL"><strong>نادرة</strong><strong> </strong><strong>جدا</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">إذا عانيت من تفاعلات تحسسية. قد تتضمن العلامات: طفح، مشاكل في البلع أو التنفس، تورم الشفاه، الوجه، الحلق، أو اللسان.</p><p dir="RTL"><strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>ليڤوفلوكساسين</strong><strong> </strong><strong>و</strong><strong> </strong><strong>اذهب</strong><strong> </strong><strong>لرؤية</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>فورا</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الخطيرة</strong><strong> </strong><strong>التالية</strong><strong> &ndash; </strong><strong>قد</strong><strong> </strong><strong>تحتاج</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>علاج</strong><strong> </strong><strong>طبي</strong><strong> </strong><strong>طارئ</strong><strong>:</strong></p><p dir="RTL"><strong>نادرة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">إسهال مائي قد يحتوي على دم، احتمال أن يرافقه تشنجات في المعدة و ارتفاع درجة الحرارة. قد تكون هذه أعراض مشكلة حادة في الأمعاء.</p><p dir="RTL">ألم و التهاب في الأوتار و الأربطة، الذي قد يؤدي إلى حدوث تمزق. غالبا ما يتأثر الوتر الأخلس (الوتر الذي يقع في المنطقة الخلفية من الكاحل).</p><p dir="RTL">نوبات&nbsp; ظهور أعراض مفاجئة (تشنجات).</p><p dir="RTL"><strong>نادرة</strong><strong> </strong><strong>جدا</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">شعور بالحرقة، الإحساس بوخز خفيف، ألم أو تنميل. قد تكون هذه علامات ما يسمى &quot;بالاعتلال العصبي&quot;.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>أخرى</strong><strong>:</strong></p><p dir="RTL">طفح جلدي حاد الذي قد يتضمن تنفطات (بثور) أو تقشير الجلد حول الشفاه، العيون، الفم، الأنف و الأعضاء التناسلية.</p><p dir="RTL">فقدان الشهية، اصفرار الجلد والمنطقة البيضاء في العيون، بول داكن اللون، حكة أو التألم باللمس في المعدة (البطن). قد تكون هذه علامات على وجود مشاكل في الكبد التي قد تتضمن قصور وظيفة الكبد الذي يسبب الوفاة.</p><p dir="RTL">إذا عانيت من ضعف البصر أو إذا كنت تعاني من أي اضطرابات أخرى في العين خلال تناول ليڤوفلوكساسين، يجب عليك استشارة أخصائي العيون على الفور.</p><p dir="RTL"><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>أصبحت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>التالية</strong><strong> </strong><strong>خطيرا</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>استمر</strong><strong> </strong><strong>لفترة</strong><strong> </strong><strong>أطول</strong><strong> </strong><strong>من</strong><strong> </strong><strong>بضعة</strong><strong> </strong><strong>أيام</strong><strong>:</strong></p><p dir="RTL"><strong>شائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>)</strong></p><p dir="RTL">مشاكل في النوم.</p><p dir="RTL">صداع، الشعور بالدوار.</p><p dir="RTL">الشعور بالغثيان (الشعور بالغثيان، قيء) و إسهال.</p><p dir="RTL">ارتفاع مستوى بعض إنزيمات الكبد في الدم.</p><p dir="RTL"><strong>غير</strong><strong> </strong><strong>شائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">تغيرات في عدد البكتيريا أو الفطريات الأخرى، الالتهاب الناتج عن الفطريات يسمى المبيضات، الذي قد يحتاج إلى العلاج.</p><p dir="RTL">تغيرات في عدد خلايا الدم البيضاء التي ظهرت في نتائج بعض فحوصات الدم (نقص عدد&nbsp;كريات الدم البيضاء، فرط الحمضات).</p><p dir="RTL">الشعور بالتوتر (القلق)، الشعور بالارتباك، الشعور بالعصبية، الشعور بالنعاس، ارتعاش، الشعور بالدوران (دوخة).</p><p dir="RTL">قصر النفس (ضيق النفس).</p><p dir="RTL">تغيرات في طريقة تذوق الأشياء، فقدان الشهية، اضطراب المعدة أو عسر الهضم، ألم في منطقة المعدة، الشعور بالانتفاخ (غازات) أو إمساك.</p><p dir="RTL">حكة و طفح جلدي، حكة حادة أو شرى، التعرق الزائد (فرط التعرق).</p><p dir="RTL">ألم المفاصل أو العضلات.</p><p dir="RTL">قد تظهر فحوصات الدم نتائج غير طبيعية بسبب وجود مشاكل في الكبد (زيادة البيليروبين) أو في الكلى (زيادة الكرياتينين).</p><p dir="RTL">الشعور بالضعف العام.</p><p dir="RTL"><strong>نادرة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>يؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">ظهور الكدمات و النزيف بسهولة بسبب انخفاض عدد الصفيحات الدموية (قلة الصفيحات).</p><p dir="RTL">انخفاض عدد خلايا الدم البيضاء (قلة العدلات).</p><p dir="RTL">الاستجابة المناعية المفرطة (فرط الحساسية).</p><p dir="RTL">انخفاض مستوى السكر في الدم. هذا مهم للاشخاص الذين يعانون من داء السكري.</p><p dir="RTL">رؤية أو سماع أشياء غير موجودة (هلوسات، جنون العظمة)، تغيرات في الرأي و الأفكار (التفاعلات الذهانية)، يرافقه خطر وجود أفكار أو أفعال إنتحارية.</p><p dir="RTL">الشعور بالإكتئاب، مشاكل عقلية، الشعور بعدم الراحة (هيجان)، أحلام أو كوابيس غير طبيعية.</p><p dir="RTL">الشعور بالوخز في اليدين و القدمين (تشوش الحس).</p><p dir="RTL">مشاكل في السمع (طنين الأذن) أو الرؤية (ضبابية الرؤية).</p><p dir="RTL">نبضات القلب سريعة بشكل غير معتاد (تسارع نبضات القلب) أو انخفاض ضغط الدم.</p><p dir="RTL">ضعف العضلات. هذا مهم للأشخاص الذين يعانون من الوهن العضلي الوبيل (مرض نادر في الجهاز العصبي).</p><p dir="RTL">تغيرات في طريقة عمل الكلى و أحيانا قصور وظيفة الكلى الذي قد يكون بسبب تفاعل تحسسي في الكلى يسمى التهاب الكلية الخلالي.</p><p dir="RTL">حمى.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>أخرى</strong><strong>:</strong></p><p dir="RTL">انخفاض عدد خلايا الدم الحمراء (فقر الدم): هذا قد يجعل الجلد شاحبا أو أصفر بسبب تلف خلايا الدم الحمراء؛ انخفاض عدد جميع أنواع خلايا الدم (قلة عدد خلايا الدم).</p><p dir="RTL">حمى، تقرح الحلق والشعور العام بأنك لست على ما يرام والذي يكون مستمر. هذا قد يكون نتيجة انخفاض عدد خلايا الدم البيضاء (ندرة المحببات).</p><p dir="RTL">ضعف الدورة الدموية (صدمة تشبه الحساسية).</p><p dir="RTL">ارتفاع مستويات السكر في الدم، أو انخفاض مستويات السكر في الدم الذي يؤدي إلى الغيبوبة (غيبوبة ناتجة عن انخفاض مستوى السكر في الدم). هذا مهم للأشخاص الذين يعانون من داء السكري.</p><p dir="RTL">تغيرات في حاسة الشم، فقدان الشم أو التذوق (اضطراب حاسة الشم، فقدان حاسة الشم، فقدان حاسة التذوق).</p><p dir="RTL">مشاكل في الحركة والمشي (خلل الحركة، الأعراض خارج السبيل الهرمي [هي الأعراض التي ترتبط نموذجيا بالنظام خارج&nbsp;السبيل الهرمي&nbsp;ل?????لقشرة المخية&nbsp;ف?ي&nbsp;الدماغ]).</p><p dir="RTL">فقدان مؤقت للوعي أو الوضعية (إغماء).</p><p dir="RTL">فقدان مؤقت للرؤية.</p><p dir="RTL">ضعف أو فقدان السمع.</p><p dir="RTL">سرعة نظمية نبضات القلب بشكل غير طبيعي، عدم انتظام نبضات القلب المهدد للحياة والذي&nbsp; يتضمن توقف القلب، تغير في نظمية نبضات القلب (يسمى &quot;إطالة فترة QT&quot;، والذي يظهر في التخطيط الكهربائي للقلب، النشاط الكهربائي للقلب).</p><p dir="RTL">صعوبة في التنفس أو أزيز تنفسي (تشنج القصبات).</p><p dir="RTL">تفاعلات الرئة التحسسية.</p><p dir="RTL">التهاب البنكرياس.</p><p dir="RTL">التهاب الكبد.</p><p dir="RTL">زيادة حساسية الجلد لأشعة الشمس والأشعة فوق البنفسجية (الحساسية للضوء).</p><p dir="RTL">التهاب الأوعية الدموية التي تحمل الدم حول الجسم بسبب تفاعل تحسسي.</p><p dir="RTL">التهاب النسيج داخل الفم (التهاب الفم).</p><p dir="RTL">تمزق العضلات و تلف العضلات (انحلال&nbsp;ا??????لعضلات المخططـة).</p><p dir="RTL">احمرار المفاصل وتورمها (التهاب المفاصل).</p><p dir="RTL">ألم، يتضمن ألم في الظهر، الصدر و الأطراف.</p><p dir="RTL">نوبات البرفرية للأشخاص الذين يعانون من البرفرية (مرض أيضي نادر جدا).</p><p dir="RTL">صداع مستمر مع أو بدون ضبابية الرؤية (ارتفاع ضغط الدم الحميد داخل الجمجمة).</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>عانيت</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية،</strong><strong> </strong><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>. </strong><strong>بما</strong><strong> </strong><strong>في</strong><strong> </strong><strong>ذلك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>محتملة</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>مذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة</strong><strong>.</strong></p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول الأطفال و نظرهم.</p><p dir="RTL">لا تستعمل<strong> </strong><strong>فلوكسميد</strong><strong><sup>&reg; </sup></strong>بعد تاريخ انتهاء الصلاحية (EXP) المذكورعلى الملصق و العلبة الخارجية.</p><p dir="RTL">تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL"><strong>فلوكسميد</strong><strong><sup>&reg;&nbsp; </sup></strong>أقراص: يحفظ&nbsp; بدرجة حرارة دون 30 &deg;م.</p><p dir="RTL">يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي ليڤوفلوكساسين (هيميهيدريت).</p><p dir="RTL">المكونات الأخرى هي ميكروكريستالين سليلوز، جلايكولات نشا الصوديوم، بوڤيدون K30 ، سيليكا غروية لا مائية، ستيرات المغنيسيوم، أوبادري OY-L أبيض، أكسيد الحديد الأسود، أكسيد الحديد الأصفر، بولي إيثيلين جلايكول 6000.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>فلوكسميد</strong><strong><sup>&reg;</sup></strong><strong> </strong>750 ملغم أقراص هي أقراص مغلفة بيضاوية الشكل ذات لون عاجي إلى أصفر مائل إلى البني، محدبة الوجهين، محفور على أحد الأوجه H22 ، معبأة في عبوات بولي إيثيلين جلايكول عالي الكثافة، معدة للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم</strong><strong> </strong><strong>العبوة</strong><strong>:</strong> 7 أقراص مغلفة /عبوة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong>:</strong></p><p dir="RTL"><strong>&bull;</strong><strong>المملكة</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>السعودية</strong><strong>:</strong></p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الالكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>&bull; </strong><strong>دول</strong><strong> </strong><strong>الخليج</strong><strong> </strong><strong>العربي</strong><strong> </strong><strong>الأخرى</strong><strong>:</strong></p><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك</strong><strong> </strong><strong>حق</strong><strong> </strong><strong>التسويق</strong><strong> </strong><strong>والشركة</strong><strong> </strong><strong>المصنعة</strong><strong>:</strong></p><p dir="RTL">مدينة الدواء للصناعات الدوائية - المملكة العربية السعودية.</p><p dir="RTL">المدينة الصناعية الأولى، المرحلة الخامسة، جدة - المملكة العربية السعودية.</p><p dir="RTL">هاتف: 00966920003288</p><p dir="RTL">جوال: 00966555786968</p><p dir="RTL">ص.ب: 4072 - جدة 22429</p><p dir="RTL">بريد الكتروني: info@medcitypharma.com</p><p dir="RTL">&nbsp;</p><p dir="RTL">هذه النشرة لا تحتوي على جميع المعلومات عن المستحضر. إذا كان لديك أية أسئلة أو لم تكن متأكدا من أي شيء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 2024/ 12     
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Floxmed® 750 Film Coated Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Floxmed® 750 mg: Each film-coated tablet contains 750 mg Levofloxacin (hemihydrate).

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets.

Floxmed® 750mg Film Coated Tablet, Beige to brownish yellow oval deep biconvex film coated tablets engraved with H22 on one face and plain on the other face, packed in HDPE Jars, intended for oral use.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Floxmed<sup>&reg; </sup></strong>tablets are indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute bacterial sinusitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute exacerbations of chronic bronchitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Community‐acquired pneumonia</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Complicated skin and soft tissue infections.</p><p>For the above‐mentioned infections <strong>Floxmed<sup>&reg; </sup></strong>should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pyelonephritis and complicated urinary tract infections (see section 4.4).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chronic bacterial prostatitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncomplicated cystitis (see section 4.4).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inhalation Anthrax: post exposure prophylaxis and curative treatment (see section 4.4). <strong>Floxmed<sup>&reg; </sup></strong>may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Floxmed<sup>&reg; </sup></strong>tablets administered once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.</p><p><strong>Treatment time</strong></p><p>The duration of therapy varies according to the course of the disease (see table below). As with antibiotic therapy in general, administration of <strong>Floxmed<sup>&reg; </sup></strong>should be continued for a minimum of 48 to 72 hours after the patient has become afebrile or evidence of bacterial eradication has been obtained.</p><p>The following dose recommendations can be given for <strong>Floxmed<sup>&reg;</sup></strong>:</p><p>Dosage in patients with normal renal function (creatinine clearance &gt; 50 ml/min)</p><table border="1" cellspacing="3" cellpadding="0"><tbody><tr><td><p><strong>Indication</strong></p></td><td><p><strong>Daily dose regimen&nbsp;(according to&nbsp;severity)</strong></p></td><td><p><strong>Duration of the treatment</strong></p><p><strong>(according to severity)</strong></p></td></tr><tr><td rowspan="2"><p>Acute bacterial sinusitis</p></td><td><p>500 mg once daily</p></td><td><p>10 &ndash; 14 days</p></td></tr><tr><td><p>750 mg every 24 hours</p></td><td><p>5 days</p></td></tr><tr><td><p>Acute bacterial exacerbations of chronic bronchitis</p></td><td><p>500 mg once daily</p></td><td><p>7 &ndash; 10 days</p></td></tr><tr><td rowspan="2"><p>Community‐acquired pneumonia</p></td><td><p>500 mg once or twice daily</p></td><td><p>7 &ndash; 14 days</p></td></tr><tr><td><p>750 mg every 24 hours<sup>&sect;</sup></p></td><td><p>5 days&sect;</p></td></tr><tr><td rowspan="2"><p>Pyelonephritis</p></td><td><p>500 mg once daily</p></td><td><p>7 &ndash; 10 days</p></td></tr><tr><td><p>750 mg every 24 hours#</p></td><td><p>5 days<sup>#</sup></p></td></tr><tr><td><p>Uncomplicated cystitis</p></td><td><p>250 mg once daily</p></td><td><p>3 days</p></td></tr><tr><td rowspan="2"><p>Complicated urinary tract infections</p></td><td><p>500 mg once daily</p></td><td><p>7‐14 days</p></td></tr><tr><td><p>750 mg every 24 hours*</p></td><td><p>5 days*</p></td></tr><tr><td><p>Chronic bacterial prostatitis</p></td><td><p>500 mg once daily</p></td><td><p>28 days</p></td></tr><tr><td rowspan="2"><p>Complicated skin and soft tissue infections</p></td><td><p>500 mg once or twice daily</p></td><td><p>7 &ndash; 14 days</p></td></tr><tr><td><p>750 mg every 24 hours</p></td><td><p>7 &ndash; 14 days</p></td></tr><tr><td><p>Inhalation Anthrax</p></td><td><p>500 mg once daily</p></td><td><p>8 weeks</p></td></tr></tbody></table><p><sup>&sect;</sup> Due to Streptococcus pneumoniae (excluding multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae</p><p>*Due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis.</p><p><sup>#</sup>Due to E. coli, including cases with concurrent bacteremia.</p><p><strong>Special populations</strong></p><p><strong>Impaired renal function (creatinine clearance &le; 50)</strong></p><p><strong>Dose&nbsp;regime</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>Normal</strong></p></td><td style="vertical-align:top"><p><strong>750 mg/24 h</strong></p></td></tr><tr><td style="vertical-align:top"><p>Creatinine clearance</p></td><td style="vertical-align:top"><p>First dose: 750 mg</p></td></tr><tr><td style="vertical-align:top"><p>50‐20 ml/min</p></td><td style="vertical-align:top"><p>Then: 750 mg / 48 h</p></td></tr><tr><td style="vertical-align:top"><p>19‐10 ml/min</p></td><td style="vertical-align:top"><p>Then: 500 mg /48 h</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 10 ml/min (including haemodialysis and CAPD)<sup>1</sup></p></td><td style="vertical-align:top"><p>Then: 500 mg /48 h</p></td></tr></tbody></table><p>1 No additional doses are required after haemodialysis or continuous ambulatory peritoneal dialysis (CAPD)</p><p><strong>Impaired liver function</strong></p><p>No adjustment of dosage is required since levofloxacin is not metabolised to any relevant extent by the liver and is mainly excreted by the kidneys.</p><p><strong>Elderly population</strong></p><p>No adjustment of dose is required in the elderly, other than that imposed by consideration of renal function (see section 4.4 &ldquo;Tendinitis and tendon rupture&rdquo; and &ldquo;QT interval prolongation&rdquo;).</p><p><strong>Paediatric population</strong></p><p>Levofloxacin is contraindicated in children and growing adolescents (see section 4.3).</p><p>Method of administration</p><p><strong>Floxmed<sup>&reg; </sup></strong>tablets should be swallowed without crushing and with sufficient amount of liquid. They may be divided at the score line to adapt the dose. The tablets may be taken during meals or between meals. <strong>Floxmed<sup>&reg; </sup></strong>should be taken at least two hours before or after iron salts, zinc salts, magnesium‐ or aluminium‐containing antacids, or didanosine&nbsp;(only didanosine formulations with aluminium or magnesium containing buffering agents),&nbsp;and sucralfate administration since reduction of absorption can occur (see section 4.5).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Floxmed® must not be used:
•	In patients hypersensitive to levofloxacin or other quinolones or to any of the excipients listed in section 6.1.
•	In patients with epilepsy.
•	In patients with history of tendon disorders related to fluoroquinolone administration.
•	In children or growing adolescents.
•	During pregnancy.
•	In breast‐feeding women.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Methicillin</strong><strong>‐</strong><strong>resistant Staphylococcus aureus (MRSA)</strong></p><p>Methicillin‐resistant S. aureus are very likely to possess co‐resistance to fluoroquinolones, including levofloxacin. Therefore levofloxacin is not recommended for the treatment of known or suspected MRSA infections unless laboratory results have confirmed susceptibility of the organism to levofloxacin (and commonly recommended antibacterial agents for the treatment of MRSA‐infections are considered inappropriate).</p><p>Levofloxacin may be used in the treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.</p><p>Resistance to fluoroquinolones of E. coli &ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in E. coli to fluoroquinolones.</p><p>Inhalation Anthrax: Use in humans is based on in vitro Bacillus anthracis susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.</p><p><strong>Tendinitis and tendon rupture</strong></p><p>Tendinitis may rarely occur. It most frequently involves the Achilles tendon and may lead to tendon rupture. Tendinitis and tendon rupture, sometimes bilateral, may occur within 48 hours of starting treatment with levofloxacin and have been reported up to several months after discontinuation of treatment. The risk of tendinitis and tendon rupture is increased in patients aged over 60 years, in patients receiving daily doses of 1000 mg and in patients using corticosteroids. The daily dose should be adjusted in elderly patients based on creatinine clearance (see section 4.2). Close monitoring of these patients is therefore necessary if they are prescribed Levofloxacin. All patients should consult their physician if they experience symptoms of tendinitis. If tendinitis is suspected, treatment with Levofloxacin must be halted immediately, and appropriate treatment (e.g. immobilisation) must be initiated for the affected tendon (see sections 4.3 and 4.8).</p><p><strong>Clostridium difficile</strong><strong>‐</strong><strong>associated disease</strong></p><p>Diarrhoea, particularly if severe, persistent and/or bloody, during or after treatment with Levofloxacin (including several weeks after treatment), may be symptomatic of&nbsp;Clostridium difficile‐associated disease (CDAD). CDAD may range in severity from mild to life threatening, the most severe form of which is pseudomembranous colitis (see section 4.8). It is therefore important to consider this diagnosis in patients who develop serious diarrhoea during or after treatment with levofloxacin. If CDAD is suspected or confirmed, Levofloxacin Tablets should be stopped immediately and appropriate treatment initiated without delay (e.g. oral metronidazole or vancomycin). Medicinal products inhibiting the peristalsis are contraindicated in this clinical situation.</p><p><strong>Patients predisposed to seizures</strong></p><p>Quinolones may lower the seizure threshold and may trigger seizures. Levofloxacin is contraindicated in patients with a history of epilepsy (see section 4.3) and, as with other quinolones, should be used with extreme caution in patients predisposed to seizures, or concomitant treatment with active substances that lower the cerebral seizure threshold, such as theophylline (see section 4.5). In case of convulsive seizures (see section 4.8), treatment with levofloxacin should be discontinued.</p><p><strong>Patients with G</strong><strong>‐</strong><strong>6</strong><strong>‐</strong><strong> phosphate dehydrogenase deficiency</strong></p><p>Patients with latent or actual defects in glucose‐6‐phosphate dehydrogenase activity may be prone to haemolytic reactions when treated with quinolone antibacterial agents. Therefore, if levofloxacin has to be used in these patients, potential occurrence of haemolysis should be monitored.</p><p><strong>Patients with renal impairment</strong></p><p>Since levofloxacin is excreted mainly by the kidneys, the dose of <strong>Floxmed<sup>&reg;</sup></strong> should be adjusted in patients with renal impairment. (see section 4.2).</p><p><strong>Hypersensitivity reactions</strong></p><p>Levofloxacin can cause serious, potentially fatal hypersensitivity reactions (e.g. angioedema to anaphylactic shock), occasionally following the initial dose (see section 4.8). Patients should discontinue treatment immediately and contact their physician or an emergency physician, who will initiate appropriate emergency measures.</p><p><strong>Severe bullous reactions</strong></p><p>Cases of severe bullous skin reactions such as Stevens‐Johnson syndrome or toxic epidermal necrolysis have been reported with levofloxacin (see section 4.8). Patients should be advised to contact their doctor immediately prior to continuing treatment if skin and/or mucosal reactions occur.</p><p><strong>Dysglycaemia</strong></p><p>As with all quinolones, disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia have been reported, usually in diabetic patients receiving concomitant treatment with an oral hypoglycaemic agent (e.g., glibenclamide) or with insulin. Cases of hypoglycaemic coma have been reported. In diabetic patients, careful monitoring of blood glucose is recommended (see section 4.8).</p><p><strong>Prevention of photosensitisation</strong></p><p>Photosensitisation has been reported with levofloxacin (see section 4.8). It is recommended that patients should not expose themselves unnecessarily to strong sunlight or to artificial UV rays (e.g. sunray lamp, solarium), during treatment and for 48 hours following treatment discontinuation in order to prevent photosensitisation.</p><p><strong>Patients treated with Vitamin K antagonists</strong></p><p>Due to possible increase in coagulation tests (PT/INR) and/or bleeding in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin), coagulation tests should be monitored when these drugs are given concomitantly (see section 4.5).</p><p><strong>Psychotic reactions</strong></p><p>Psychotic reactions have been reported in patients receiving quinolones, including levofloxacin.</p><p>In very rare cases these have progressed to suicidal thoughts and self‐endangering behavior sometimes after only a single dose of levofloxacin (see section 4.8). In the event that the patient develops these reactions, levofloxacin should be discontinued and appropriate measures instituted. Caution is recommended if levofloxacin is to be used in psychotic patients or in patients with a history of psychiatric disease.</p><p><strong>QT interval prolongation</strong></p><p>Caution should be taken when using fluoroquinolones, including levofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Congenital long QT syndrome.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncorrected electrolyte imbalance (e.g. hypokalemia, hypomagnesemia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cardiac disease (e.g. heart failure, myocardial infarction, bradycardia) Elderly patients and women may be more sensitive to QTc‐prolonging medications.</p><p>Therefore, caution should be taken when using fluoroquinolones, including levofloxacin, in these populations. (see section 4.2&nbsp;Elderly, section 4.5, section 4.8, section 4.9).</p><p><strong>Peripheral neuropathy</strong></p><p>Sensory or sensorimotor peripheral neuropathy have been reported in patients receiving fluoroquinolones, including levofloxacin, which can be rapid in its onset (see section 4.8).</p><p>Levofloxacin should be discontinued if the patient experiences symptoms of neuropathy in order to prevent the development of an irreversible condition.</p><p><strong>Hepatobiliary disorders</strong></p><p>Cases of hepatic necrosis up to fatal hepatic failure have been reported with levofloxacin, primarily in patients with severe underlying diseases, e.g. sepsis (see section 4.8). Patients should be advised to stop treatment and contact their doctor if signs and symptoms of hepatic disease develop such as anorexia, jaundice, dark urine, pruritus or tender abdomen.</p><p><strong>Exacerbation of myasthenia gravis</strong></p><p>Fluoroquinolones, including levofloxacin, have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Postmarketing serious adverse reactions, including deaths and the requirement for respiratory support, have been associated with fluoroquinolone use in patients with myasthenia gravis.</p><p>Levofloxacin is not recommended in patients with a known history of myasthenia gravis.</p><p><strong>Vision disorders</strong></p><p>If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately (see sections 4.7 and 4.8).</p><p><strong>Superinfection</strong></p><p>The use of levofloxacin, especially if prolonged, may result in overgrowth of non‐ susceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken.</p><p><strong>Interference with laboratory tests</strong></p><p>In patients treated with levofloxacin, determination of opiates in urine may give false‐ positive results. It may be necessary to confirm positive opiate screens by more specific method.</p><p>Levofloxacin may inhibit the growth of&nbsp;Mycobacterium tuberculosis&nbsp;and, therefore, may give false‐negative results in the bacteriological diagnosis of tuberculosis.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Effect of other medicinal products on levofloxacin</strong></p><p><strong>Iron salts, zinc salts, magnesium</strong><strong>‐</strong><strong> or aluminium</strong><strong>‐</strong><strong>containing antacids, didanosine</strong></p><p>Levofloxacin absorption is significantly reduced when iron salts, or magnesium‐ or aluminium containing antacids, or didanosine (only didanosine formulations with aluminium or magnesium containing buffering agents) are administered concomitantly with <strong>Floxmed<sup>&reg;</sup></strong>. Concurrent administration of fluoroquinolones with multi‐vitamins containing zinc appears to reduce their oral absorption. It is recommended that preparations containing divalent or trivalent cations such as iron salts, zinc salts or magnesium‐ or aluminium‐containing antacids, or didanosine (only didanosine formulations with aluminium or magnesium containing buffering agents)&nbsp;should not be taken 2 hours before or after <strong>Floxmed<sup>&reg;</sup></strong> administration (see section 4.2). Calcium salts have a minimal effect on the oral absorption of levofloxacin.</p><p><strong>Sucralfate</strong></p><p>The bioavailability of <strong>Floxmed<sup>&reg;</sup></strong> is significantly reduced when administered together with sucralfate. If the patient is to receive both sucralfate and <strong>Floxmed<sup>&reg;</sup></strong>, it is best to administer sucralfate 2 hours after the <strong>Floxmed<sup>&reg;</sup></strong> administration (see section 4.2).</p><p><strong>Theophylline, fenbufen or similar non</strong><strong>‐</strong><strong>steroidal anti</strong><strong>‐</strong><strong>inflammatory drugs</strong></p><p>No pharmacokinetic interactions of levofloxacin were found with theophylline in a clinical study.</p><p>However a pronounced lowering of the cerebral seizure threshold may occur when quinolones are given concurrently with theophylline, non‐steroidal anti‐inflammatory drugs, or other agents which lower the seizure threshold.</p><p>Levofloxacin concentrations were about 13 % higher in the presence of fenbufen than when administered alone.</p><p><strong>Probenecid and cimetidine</strong></p><p>Probenecid and cimetidine had a statistically significant effect on the elimination of levofloxacin.</p><p>The renal clearance of levofloxacin was reduced by cimetidine (24 %) and probenecid (34 %). This is because both drugs are capable of blocking the renal tubular secretion of levofloxacin. However, at the tested doses in the study, the statistically significant kinetic differences are unlikely to be of clinical relevance.</p><p>Caution should be exercised when levofloxacin is coadministered with drugs that effect the tubular renal secretion such as probenecid and cimetidine, especially in renally impaired patients.</p><p><strong>Other relevant information</strong></p><p>Clinical pharmacology studies have shown that the pharmacokinetics of levofloxacin were not affected to any clinically relevant extent when levofloxacin was administered together with the following drugs:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Calcium carbonate.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glibenclamide.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ranitidine.</p><p><strong>Effect of levofloxacin on other medicinal products</strong></p><p><strong>Ciclosporin</strong></p><p>The half‐life of ciclosporin was increased by 33 % when co‐administered with levofloxacin.</p><p><strong>Vitamin K antagonists</strong></p><p>Increased coagulation tests (PT/INR) and/or bleeding, which may be severe, have been reported in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin).</p><p>Coagulation tests, therefore, should be monitored in patients treated with vitamin K antagonists (see section 4.4).</p><p><strong>Drugs known to prolong the QT interval</strong></p><p>Levofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotic). (See section 4.4 QT interval prolongation).</p><p><strong>Other relevant information</strong></p><p>In a pharmacokinetic interaction study, levofloxacin did not affect the pharmacokinetics of theophylline (which is a probe substrate for CYP1A2), indicating that levofloxacin is not a CYP1A2 inhibitor.</p><p><strong>Other forms of interactions</strong></p><p><strong>Meals</strong></p><p>There is no clinically relevant interaction with food. <strong>Floxmed<sup>&reg;</sup></strong> may therefore be administered regardless of food intake.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There are limited amount of data with respect to the use of levofloxacin in pregnant women.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). However in the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight‐ bearing cartilage of the growing organism, levofloxacin must not be used in pregnant women (see sections 4.3 and 5.3).</p><p><strong>Breast</strong><strong>‐</strong><strong>feeding</strong></p><p>Levofloxacin tablets are contraindicated in breast‐feeding women. There is insufficient information on the excretion of levofloxacin in human milk; however other fluoroquinolones are excreted in breast milk. In the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight‐bearing cartilage of the growing organism, levofloxacin must not be used in breast‐feeding women (see sections 4.3 and 5.3).</p><p><strong>Fertility</strong></p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some undesirable effects (e.g. dizziness/vertigo, drowsiness, visual disturbances) may impair the patient&#39;s ability to concentrate and react, and therefore may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The information given below is based on data from clinical studies in more than 8300 patients and on extensive post marketing experience.<br />Frequencies are defined using the following convention: very common (&ge; 1/10), common (&ge; 1/100, &lt;&nbsp;1/10), uncommon (&ge; 1/1,000, &lt; 1/100), rare (&ge; 1/10,000, &lt; 1/1,000), very rare (&lt; 1/10,000), not&nbsp;known (cannot be estimated from the available data). Within each frequency grouping, undesirable&nbsp;effects are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>System organ class</strong></p></td><td><p><strong>Common</strong></p><p><strong>(&ge; 1/100 to &lt; 1/10 )</strong></p></td><td><p><strong>Uncommon</strong></p><p><strong>(&ge; 1/1,000 to &lt; 1/100)</strong></p></td><td><p><strong>Rare</strong></p><p><strong>(&ge; 1/10,000 to &lt; 1/1,000)</strong></p></td><td><p><strong>Not known (cannot be estimated from available data)</strong></p></td></tr><tr><td><p>Infections and infestations</p></td><td><p>&nbsp;</p></td><td><p>Fungal infection including Candida infection</p><p>Pathogen resistance</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Blood and lymphatic system disorders</p></td><td><p>&nbsp;</p></td><td><p>Leukopenia Eosinophilia</p></td><td><p>Thrombocytopenia Neutropenia</p></td><td><p>Pancytopenia Agranulocytosis Haemolytic anaemia</p></td></tr><tr><td><p>Immune system disorders</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>Angioedema Hypersensitivity (see section 4.4)</p></td><td><p>Anaphylactic shock<sup>a</sup>&nbsp;Anaphylactoid shock&nbsp;<sup>a</sup>&nbsp;(see section 4.4)</p></td></tr><tr><td><p>Metabolism and nutrition disorders</p></td><td><p>&nbsp;</p></td><td><p>Anorexia</p></td><td><p>Hypoglycaemia particularly in diabetic patients (see section 4.4)</p></td><td><p>Hyperglycaemia Hypoglycaemic coma (see section 4.4)</p></td></tr><tr><td><p>Psychiatric disorders</p></td><td><p>Insomnia</p></td><td><p>Anxiety Confusional state Nervousness</p></td><td><p>Psychotic reactions (with e.g. hallucination, paranoia)</p><p>Depression Agitation Abnormal dreams Nightmares</p></td><td><p>Psychotic disorders with self‐endangering behaviour including suicidal ideation or suicide attempt (see section 4.4)</p></td></tr><tr><td><p>Nervous system disorders</p></td><td><p>Headache Dizziness</p></td><td><p>Somnolence Tremor Dysgeusia</p></td><td><p>Convulsion (see sections 4.3 and 4.4) Paraesthesia</p></td><td><p>Peripheral sensory neuropathy (see section&nbsp; 4.4) Peripheral sensory motor neuropathy (see section 4.4) Parosmia including anosmia</p><p>Dyskinesia Extrapyramidal disorder Ageusia Syncope</p><p>Benign intracranial hypertension</p></td></tr><tr><td><p>Eye disorders</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>Visual disturbances such as blurred vision (see section 4.4)</p></td><td><p>Transient vision loss (see section 4.4)</p></td></tr><tr><td><p>Ear and Labyrinth disorders</p></td><td><p>&nbsp;</p></td><td><p>Vertigo</p></td><td><p>Tinnitus</p></td><td><p>Hearing loss Hearing impaired</p></td></tr><tr><td><p>Cardiac disorders</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>Tachycardia, Palpitation</p></td><td><p>Ventricular tachycardia, which may result in cardiac arrest</p><p>Ventricular&nbsp; arrhythmia and torsade de pointes (reported predominantly in patients with risk factors of QT prolongation), electrocardiogram QT prolonged (see sections 4.4 and 4.9)</p></td></tr><tr><td><p>Vascular disorders</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>Hypotension</p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Respiratory, thoracic and mediastinal disorders</p></td><td><p>&nbsp;</p></td><td><p>Dyspnoea</p></td><td><p>&nbsp;</p></td><td><p>Bronchospasm Pneumonitis allergic</p></td></tr><tr><td><p>Gastro‐ intestinal disorders</p></td><td><p>Diarrhoea Vomiting Nausea</p></td><td><p>Abdominal pain Dyspepsia Flatulence Constipation</p></td><td><p>&nbsp;</p></td><td><p>Diarrhoea &ndash;&nbsp; haemorrhagic&nbsp; which in very rare cases may be indicative of enterocolitis,&nbsp; including pseudomembranous colitis (see section 4.4) Pancreatitis</p></td></tr><tr><td><p>Hepatobiliary disorders</p></td><td><p>Hepatic enzyme increased (ALT/AST, alkaline phosphatase, GGT)</p></td><td><p>Blood bilirubin increased</p></td><td><p>&nbsp;</p></td><td><p>Jaundice and severe liver injury, including cases with fatal acute liver failure, primarily in patients with severe underlying diseases (see section 4.4) Hepatitis</p></td></tr><tr><td><p>Skin and subcutaneous tissue&nbsp; disorders&nbsp;<sup>b</sup></p></td><td><p>&nbsp;</p></td><td><p>Rash</p><p>Pruritus</p><p>Urticaria</p><p>Hyperhidrosis</p></td><td><p>&nbsp;</p></td><td><p>Toxic epidermal necrolysis</p><p>Stevens‐Johnson syndrome</p><p>Erythema multiforme</p><p>Photosensitivity reaction (see section 4.4)</p><p>Leukocytoclastic vasculitis</p><p>Stomatitis</p></td></tr><tr><td><p>Musculoskeletal and connective tissue disorders</p></td><td><p>&nbsp;</p></td><td><p>Arthralgia</p><p>Myalgia</p></td><td><p>Tendon disorders (see sections 4.3 and 4.4) including tendinitis (e.g. Achilles tendon)</p><p>Muscular weakness which may be of special importance in patients with myasthenia gravis (see section 4.4 )</p></td><td><p>Rhabdomyolysis</p><p>Tendon rupture (e.g.</p><p>Achilles tendon) (see sections 4.3 and 4.4)</p><p>Ligament rupture</p><p>Muscle rupture</p><p>Arthritis</p></td></tr><tr><td><p>Renal and Urinary disorders</p></td><td><p>&nbsp;</p></td><td><p>Blood creatinine increased</p></td><td><p>Renal failure acute (e.g. due to interstitial nephritis)</p></td><td><p>&nbsp;</p></td></tr><tr><td><p>General disorders and administration site conditions</p></td><td><p>&nbsp;</p></td><td><p>Asthenia</p></td><td><p>Pyrexia</p></td><td><p>Pain (including pain in back, chest, and extremities)</p></td></tr></tbody></table><p><sup>a</sup>&nbsp;Anaphylactic and anaphylactoid reactions may sometimes occur even after the first dose.</p><p><sup>b</sup>&nbsp;Mucocutaneous reactions may sometimes occur even after the first dose</p><p>&nbsp;Other undesirable effects which have been associated with fluoroquinolone administration&nbsp;</p><p>include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attacks of porphyria in patients with porphyria.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&bull; Saudi Arabia:</strong></p><p>The National Pharmacovigilance Center (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>&bull; Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>According to toxicity studies in animals or clinical pharmacology studies performed with supratherapeutic doses, the most important signs to be expected following acute over dosage of levofloxacin are central nervous system symptoms such as confusion, dizziness, impairment of consciousness, and convulsive seizures, increases in QT interval as well as gastro‐intestinal reactions such as nausea and mucosal erosions.</p><p>CNS effects including confusional state, convulsion, hallucination, and tremor have been observed in post marketing experience.</p><p>In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Antacids may be used for protection of gastric mucosa. Haemodialysis, including peritoneal dialysis and CAPD, are not effective in removing levofloxacin from the body.</p><p>No specific antidote exists.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antiifectives for systemic use &ndash; Antibacterials for systemic use &ndash; Quinolone antibasterials &ndash; Fluoroquinolones</p><p>ATC code: J01MA12</p><p>Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class and is the S (‐) enantiomer of the racemic drug substance ofloxacin.</p><p><strong>Mechanism of action</strong></p><p>As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA‐DNA‐gyrase complex and topoisomerase IV.</p><p><strong>PK/PD relationship</strong></p><p>The degree of the bactericidal activity of levofloxacin depends on the ratio of the maximum concentration in serum (Cmax) or the area under the curve (AUC) and the minimal inhibitory concentration (MIC).</p><p><strong>Mechanism(s) of resisance</strong></p><p>Resistance to levofloxacin is acquired through a stepwise process by target site mutations in both type II topoisomerases, DNA gyrase and topoisomerase IV. Other resistance mechanisms such as permeation barriers (common in Pseudomonas aeruginosa) and efflux mechanisms may also affect susceptibility to levofloxacin.</p><p>Cross‐resistance between levofloxacin and other fluoroquinolones&nbsp;is observed.&nbsp;Due to the mechanism of action, there is generally no cross‐resistance between levofloxacin and other classes of antibacterial agents.</p><p><strong>Breakpoints</strong></p><p>The EUCAST recommended MIC breakpoints for levofloxacin, separating susceptible from intermediately susceptible organisms and intermediately susceptible from resistant organisms are presented in the below table for MIC testing (mg/L).</p><p>EUCAST clinical MIC breakpoints for levofloxacin (version 2.0, 2012‐01‐01):</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Pathogen</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriacae</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Pseudomonas spp.</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Acinetobacter spp.</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Staphylococcus spp.</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>S.pneumoniae&nbsp;1</p></td><td style="vertical-align:top"><p>&le;2 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Streptococcus A,B,C,G</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>H.influenzae2, 3&nbsp;M.catarrhalis&nbsp;3</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;1 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Non‐species related breakpoints&nbsp;4</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr></tbody></table><p>1.&nbsp;&nbsp;The breakpoints for levofloxacin relate to high dose therapy.</p><p>2.&nbsp;&nbsp;Low‐level fluoroquinolone resistance (ciprofloxacin MICs of 0.12‐0.5 mg/l) may occur but there is no evidence that this resistance is of clinical importance in respiratory tract infections with&nbsp;H. influenzae.</p><p>3.&nbsp;&nbsp;Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory. Until there is evidence regarding clinical response for confirmed isolates with MIC above the current resistant breakpoint they should be reported resistant.</p><p>4.&nbsp;&nbsp;Breakpoints apply to an oral dose of 500 mg x 1 to 500 mg x 2 and an intravenous dose of 500 mg x 1 to 500 mg x 2.</p><p>The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is s ch that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td><p><strong>Commonly susceptible species</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Aerobic Gram</strong><strong>‐</strong><strong>positive bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Bacillus anthracis</p><p>Staphylococcus aureus methicillin‐susceptible</p><p>Staphylococcus saprophyticus</p><p>Streptococci, group C and G</p><p>Streptococcus agalactiae</p><p>Streptococcus pneumoniae</p><p>Streptococcus pyogenes</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Aerobic Gram</strong><strong>‐</strong><strong> negative bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Eikenella corrodens</p><p>Haemophilus influenzae</p><p>Haemophilus para‐influenzae Klebsiella oxytoca</p><p>Moraxella catarrhalis</p><p>Pasteurella multocida</p><p>Proteus vulgaris</p><p>Providencia rettgeri</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Anaerobic bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Peptostreptococcus</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Other</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Chlamydophila pneumoniae</p><p>Chlamydophila psittaci</p><p>Chlamydia trachomatis</p><p>Legionella pneumophila</p><p>Mycoplasma pneumoniae</p><p>Mycoplasma hominis</p><p>Ureaplasma urealyticum</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Species for which acquired resistance may be a problem</strong></p></td><td><p><strong>&nbsp;</strong></p></td></tr><tr><td><p><strong>Aerobic Gram</strong><strong>‐</strong><strong>positive bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Enterococcus faecalis</p><p>Staphylococcus aureus methicillin‐resistant#</p><p>Coagulase negative Staphylococcus spp</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Aerobic Gram</strong><strong>‐</strong><strong> negative bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Acinetobacter baumannii</p><p>Citrobacter freundii</p><p>Enterobacter aerogenes</p><p>Enterobacter cloacae</p><p>Escherichia coli</p><p>Klebsiella pneumoniae</p><p>Morganella morganii</p><p>Proteus mirabilis</p><p>Providencia stuartii</p><p>Pseudomonas aeruginosa</p><p>Serratia marcescens</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Anaerobic bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Bacteroides fragilis</p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Inherently resistant Strains</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p><strong>Aerobic Gram</strong><strong>‐</strong><strong>positive bacteria</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Enterococcus faecium</p></td><td><p>&nbsp;</p></td></tr></tbody></table><p># Methicillin‐resistant S. aureus are very likely to possess co‐resistance to fluoroquinolones, including levofloxacin.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Orally administered levofloxacin is rapidly and almost completely absorbed with peak plasma concentrations being obtained within 1‐ 2 h. The absolute bioavailability is 99‐ 100 %.</p><p>Food has little effect on the absorption of levofloxacin.</p><p>Steady state conditions are reached within 48 hours following a 500 mg once or twice daily dosage regimen.</p><p><strong>Distribution</strong></p><p>Approximately 30 ‐ 40 % of levofloxacin is bound to serum protein. The mean volume of distribution of levofloxacin is approximately 100 l after single and repeated 500 mg doses, indicating widespread distribution into body tissues.</p><p>Penetration into tissues and body fluids:</p><p>Levofloxacin has been shown to penetrate&nbsp;into bronchial mucosa, epithelial lining fluid, alveolar macrophages, lung tissue,&nbsp;skin&nbsp;(blister fluid),&nbsp;prostatic tissue and urine.</p><p>However, levofloxacin has&nbsp;poor penetration intro cerebro‐spinal fluid.</p><p><strong>Biotransformation</strong></p><p>Levofloxacin is metabolised to a very small extent, the metabolites being desmethyl‐ levofloxacin and levofloxacin N‐oxide. These metabolites account for &lt; 5 % of the dose excreted in urine. Levofloxacin is stereo chemically stable and does not undergo chiral inversion.</p><p><strong>Elimination</strong></p><p>Following oral and intravenous administration of levofloxacin, it is eliminated relatively slowly from the plasma (t&frac12;: 6 ‐ 8 h). Excretion is primarily by the renal route &gt; 85 % of the administered dose).</p><p>The mean apparent total body clearance of levofloxacin following a 500 mg single dose was 175 +/‐29.2 ml/min.</p><p>There are no major differences in the pharmacokinetics of levofloxacin following intravenous and oral administration, suggesting that the oral and intravenous routes are interchangeable.</p><p><strong>Linearity</strong></p><p>Levofloxacin obeys linear pharmacokinetics over a range of 50 to 1000 mg.</p><p><strong>Special populations</strong></p><p><strong>Subjects with renal insufficiency</strong></p><p>The pharmacokinetics of levofloxacin are affected by renal impairment. With decreasing renal function renal elimination and clearance are decreased, and elimination half‐lives increased as shown in the table below:</p><p>Pharmacokinetics in renal insufficiency following single oral 500 mg dose</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Clcr [ml/min]</strong></p></td><td style="vertical-align:top"><p>&lt; 20</p></td><td style="vertical-align:top"><p>20 ‐ 49</p></td><td style="vertical-align:top"><p>50 ‐ 80</p></td></tr><tr><td style="vertical-align:top"><p><strong>ClR&nbsp;[ml/min]</strong></p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>57</p></td></tr><tr><td style="vertical-align:top"><p><strong>t1/2&nbsp;[h]</strong></p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>6</p></td></tr></tbody></table><p><strong>Elderly subjects</strong></p><p>There are no significant differences in levofloxacin kinetics between young and elderly subjects, except those associated with differences in creatinine clearance.</p><p><strong>Gender differences</strong></p><p>Separate analysis for male and female subjects showed small to marginal gender differences in levofloxacin pharmacokinetics. There is no evidence that these gender differences are of clinical relevance.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non‐clinical data reveal no special hazard for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential and toxicity to reproduction and development.</p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats and its only effect on fetuses was delayed maturation as a result of maternal toxicity.</p><p>Levofloxacin did not induce gene mutations in bacterial or mammalian cells but did induce chromosome aberrations in Chinese hamster lung cells in vitro. These effects can be attributed to inhibition of topoisomerase II.&nbsp;In vivo&nbsp;tests (micronucleus, sister chromatid exchange, unscheduled DNA synthesis, dominant lethal tests) did not show any genotoxic potential.</p><p>Studies in the mouse showed levofloxacin to have phototoxic activity only at very high doses. Levofloxacin did not show any genotoxic potential in a photomutagenicity assay, and it reduced tumour development in a photocarcinogenity study.</p><p>In common with other fluoroquinolones, levofloxacin showed effects on cartilage (blistering and cavities) in rats and dogs. These findings were more marked in young animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, sodium starch glycolate, povidone K30, colloidal anhydrous silica, magnesium stearate, Opadry OY-L white, black iron oxide, yellow iron oxide, polyethylene glycol 6000.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Floxmed<sup>&reg;</sup> 750mg Film Coated Table</strong>, Beige to brownish yellow oval deep biconvex film coated tablets engraved with H22 on one face and plain on the other face, packed in HDPE Jars, intended for oral use.</p><p><strong>Pack size: </strong>7 film coated tablets/Jar.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Med City Pharma-KSA
1st Industrial city, Phase 5, Jeddah –KSA.
Tel: 00966920003288
Mobile: 00966555786968
P.O .Box: 4072 - Jeddah 22429
E-mail: info@medcitypharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>